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Abstract
Nitrite supplementation restores aortic health in chronically stressed mice.

Tyler Coblentz
Chronic stress increases the risk of developing cardiovascular disease potentially via
increases in elastic artery stiffness and endothelial dysfunction. Decreased bioavailability
of the potent vasodilator nitric oxide (NO) describes a hallmark of endothelial dysfunction.
Nitrite reduces into active NO, providing an alternative pathway of NO restoration. The
effect of nitrite supplementation on aortic endothelial function has yet to be determined in
chronically stressed mice. We hypothesized that nitrite supplementation would rescue
chronic stress-attributed impairments in aortic endothelial function.
Mice at 18 weeks of age underwent an unpredictable chronic mild stress (UCMS; 5
days/week for 7 hrs/day) paradigm to elicit a chronically stressed phenotype. Control and
stressed mice underwent 8 weeks of nitrite supplementation (50mg/L) within their drinking
water. At 26 weeks, mice were euthanized, and the thoracic aortas were removed and
positioned in a wire myograph chamber. To assess vessel health, the aortas were
precontracted with U46619 (7.5x10-9M) and exposed to increasing concentrations of
methacholine (MCh; 10-9M to 10-5M) and sodium nitroprusside (SNP; 10-9M to 10-5M).
Aortic intrinsic mechanical stiffness and carotid pulse wave velocity were further
measured. IHC staining of abdominal aorta was conducted for total collagen and medial
elastin content.
Maximal thoracic aorta percent dilation to MCh was impaired in mice that underwent
UCMS when compared to controls (71±11% vs 87±6%; p<0.05). Supplementation with
nitrite rescued aortic dilation to MCh in UCMS animals (83±7% vs 71±11%; p<0.05).
Nitrite supplementation in control (Control+nitrite) and UCMS (UCMS+nitrite) groups
showed no significant differences in MCh max dilation between controls. Further, maximal
thoracic aorta percent dilation to SNP yielded no significant differences across groups.
No differences were observed in collagen deposition, elastin content, intrinsic stiffness,
or pulse wave velocity regardless of chronic stress or nitrite treatment.
In conclusion, these data suggest an impairment in aortic endothelial function due to
chronic stress that is alleviated upon supplementation with nitrite.
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Chapter 1

Introduction

1

1.1 Background and Significance
Stress describes a deviation from homeostasis within the body under several
evoking perceived or real stimuli. Acutely, the physiologic stress response is essential to
maintaining normal functions. However, excessive activation of these mechanisms
results in a maladaptive response chronically.

75

Depression results from chronic

psychological stress exposure and provides risks for the pathogenesis of various
diseases. The National Survey on Drug Use and Health survey determined that between
2009 and 2017, in the United States alone, a 63% increase in adolescents experiencing
episodes of major depression occurred. 119 Further, 71% of young adults who underwent
a depressive episode developed severe impairment. Incident cases of depression have
increased drastically within our society causing depression to remain a global health
concern. 74
Psychological chronic stress promotes overactivation of the autonomic nervous
system, neuroendocrine, and inflammatory responses. Thus, an allostatic overload
results that primes an individual for the development of further pathology.

14

In fact,

chronic stress is reported to increase and predict the occurrence of cardiovascular
disease. Stress-induced sympathetic overactivation and oxidative stress production
create an ideal environment for the pathogenesis of vascular disease that precedes
vascular depression and cardiovascular episodes. 86 Long term stress, further, increases
the risk of cardiovascular event reoccurrence and mortality.

132

Vascular integrity and function are essential in maintaining oxygen and nutrient
distribution throughout the various physiologic systems. The large elastic arteries further
ensure smooth and consistent blood transport via the cushioning of pulsatile flow. Under
2

pathological conditions, alterations in the morphology of the vascular wall and
endothelium promote stiffness and vascular dysfunction. Increases in oxidative stress
generation and subsequent decreases in nitric oxide (NO) bioavailability disrupt the
mechanisms of vascular tone regulation, reducing vasodilatory capacity. Our lab has
previously shown decreases in endothelium dependent dilation within the aorta
cerebral vasculature of chronically stressed rats.

7

30

and

Further, impairments in endothelial

function corresponded to reduced circulating NO levels and increases in measured
reactive oxygen species. 7,9,29
The generation of oxidative stress is a hallmark of vascular dysfunction and is
mediated in part by the enzyme xanthine oxidase (XO). XO facilitates the conversion of
hypoxanthine to xanthine to uric acid and promotes the formation of O 2-∙ anions under
hypoxic and diseased states.

16

Thus, XO is directly involved in the genesis of oxidative

stress-induced endothelial dysfunction. However, XO provides a potential therapeutic
intervention in vascular dysfunction via its role in the conversion of nitrate-nitrite to NO
production. 67 Here, O2-∙ generating XO undergoes a molybdenum switch in configuration
in the presence of NADH substrate. In turn, electron flow from the FAD site promotes
indirect reduction and favors the generation of active NO from nitrite. Thus, competition
between the two XO configurations limits O2-∙ generation to favor the production of
bioactive NO.
NO is the most potent vasodilator and its availability correlates with the
endothelium’s vasodilatory capacity. NO is traditionally generated via the conversion of
L-arginine to L-citrulline by active endothelial nitric oxide synthase (eNOS). Under the
pathological conditions of chronic stress, NO bioavailability is reduced, promoting
3

endothelial dysfunction.

133

More recently, an alternative pathway of NO production, the

nitrate-nitrite-NO pathway has been discovered.

79

Here, nitrate and nitrite are reduced

by commensal bacteria and mammalian enzymes respectively without the role of eNOS.
2

Under chronic stress conditions, eNOS becomes uncoupled, reduces its NO generating

capacity, and favors O2-∙ production.

134 Thus,

activation of the nitrate-nitrite-NO pathway

can facilitate increases in NO bioavailability without fueling dysfunctional eNOS. Further,
targeting XO via supplementation with nitrite potentially increases NO production while
subsequently reducing O2-∙ generation.
Nitrite is documented as a safe and effective therapeutic in several cardiovascular
diseases.

31

It is administered easily within sodium nitrite via drinking water. Nitrite

supplementation provides a direct mechanism of increasing NO bioavailability and
reducing oxidative stress. Its effectiveness has been highlighted in ameliorating vascular
dysfunction in murine models of aging and diabetes.

110,111

Further, nitrite

supplementation has proven effective in reducing arterial stiffness in human subjects. 31,53
Supplementation with sodium nitrite provides a unique therapeutic that targets XO and
enacts dual action to preserve endothelial integrity and function.
1.2 Purpose and Specific Aims
The purpose of this study was to examine the role of sodium nitrite in preserving
vascular function and composition under chronic stress conditions. This was utilized to
better divulge the mechanisms promoting endothelial dysfunction under chronic stress.
By administering a 50mg/L dose of sodium nitrite in drinking water, we aimed to target
XO and promote its actions of NO production while reducing O 2-∙ generation. Overall, we

4

aimed to investigate the therapeutic potential of sodium nitrite in a model of chronic stress
in attenuating vascular larger elastic artery stiffness and endothelial dysfunction. We
hypothesized that sodium nitrite supplementation would ameliorate oxidative stressmediated increases in stiffness and endothelial dysfunction.
Specific Aim 1. To determine the effect of Sodium Nitrite supplementation on aortic
function in chronically stressed mice.
Hypothesis: Nitrite supplementation in chronically stressed mice will return
endothelium dependent vasodilation to that of control values.
Specific Aim 2. To determine the effect of Sodium Nitrite supplementation on aortic wall
structure in chronically stressed mice.
Hypothesis: Nitrite supplementation in chronically stressed mice will retain elastin
content and reduce collagen deposition, thus decreasing stiffness within the aortic
media.

5

Chapter 2

Literature Review

6

2.1 Functional Structure of Aorta
The aorta is the largest of the elastic arteries in the cardiovascular system that
serves two main physiological roles. First, it acts as the initial conduit of blood flow
between the heart and most peripheral areas within the body. Second, it is responsible
for dampening the pulsatile flow of the heart to provide a smooth and consistent blood
flow to more distal arteries.

136

The structure of the aorta comprises three layers, the

tunica adventitia, media, and intima.
The tunica adventitia has been traditionally understood as a region of connective
tissue, fibroblasts, and innervation. Additionally, this layer remains involved in the
migration of several immune cells between tissues and the tunica intima.

80

Further

towards the vessel lumen is the tunica media consisting of mainly elastin fibers and
smooth muscle cells responsible for the regulation of vessel diameter.

65

Spanning

throughout the tunica adventitia and media is the vasa vasorum, the blood supply
providing the vessel with oxygen and nutrients. Positioned in direct contact with the
vascular lumen is the tunica intima, a glycocalyx and single layer of endothelial cells which
detect stimuli and regulate the activity of vascular smooth muscle cells to control blood
flow via alterations in vessel tone. 49

7

Figure 1. Dynamic interactions between structural layers of the arterial wall. Lumen (Lu),
Intima (In), Media (Me), Adventitia (Ad) 80

Within these three structural layers, vessels contain associated structural proteins,
including collagen and elastin fibers; however, the relative composition of each is varied
and dependent on vessel function. Elastin fibers originate from the production of
tropoelastin monomers by vascular smooth muscle cells in the medial layer. Lysyl oxidase
enzymes facilitate proper crosslinking between tropoelastin molecules to allow further
coacervation and fibulin-driven assembly into elastin fibers. 124 These fibers then organize
into circumferential layers, alternating with vascular smooth muscle cells and collagen to
form lamellar units.

24

Lamellar unit composition varies in elastin and collagen

concentration dependent upon vessel size and pressure environment, dictating passive
mechanical arterial behavior. Vessel wall integrity is maintained at low pressures due to

8

the intrinsic mechanical properties and elasticity of elastin, whereas collagen is
responsible for resisting deformation at higher pressures.

25

Figure 2. Organization of the elastic laminae in (A) large and (B) small arteries.
L=lumen 25

Importantly, the aorta contains a higher concentration of elastin fibers within its
tunica media compared to smooth muscle cell rich distal arteries. This effect is further
varied within regions of the aorta itself. Thus, the descending thoracic aorta contains
higher concentrations of elastin 116 and vasa vasorum 117 to that of the ascending thoracic
and descending abdominal aortic regions. Ultimately, this increase in elastic properties
facilitates the brief compensatory distention of the aorta, known as the Windkessel effect,
to ensure pulsatile pressure dampening. During systole, pulsatile blood flow delivered
from the left ventricle briefly expands the aortic wall, utilizing its elasticity to store strain
energy. Upon diastole, the elasticity of the aorta facilitates a reverse in distension and

9

conversion of stored energy to work that enables continuous peripheral perfusion without
permanent deformation or energy dissipation.

25

2.2 Aortic Contractility
Blood flow throughout the circulation is strictly regulated to ensure proper nutrient
and oxygen distribution, determined by pressure and vessel resistance. Regulation
occurs through the alteration of vessel diameter and tone via vascular smooth muscle cell
(VSMC)-influenced vasoconstriction and dilation. Several mechanisms contribute to the
predominance of vasoconstriction and dilation in determining vessel tone but are
ultimately a result of intracellular calcium handling.
Vessel contractility can be modified extrinsically through neural and humoral
factors. Sympathetic stimulation promotes VSMC contraction and vasoconstriction due to
the binding of alpha-adrenergic receptors by norepinephrine.

113

Further, hormonal

influence via vasopressin and angiotensin II results in vasoconstriction through the
binding of V1 and AT1 receptors respectively and the activation of a phospholipase C
pathway. Here, the formation of inositol 1,4,5-triphosphate (IP3) and diacyl glycerol
promotes calcium influx.

98

Regardless of the mechanism of transduction, increased

intracellular calcium in combination with calmodulin activates myosin light chain kinase
(MLCK) to induce VSMC contraction and thus vasoconstriction. Additionally, vasodilation
can occur extrinsically via the binding of beta-2 agonists to beta-2 adrenergic receptors,
reducing MLCK activity due to increased cAMP levels.

8

Intrinsic control of vascular tone and contractility occurs through humoral
mechanisms independent or dependent of the role of endothelial cells as well as

10

mechanically, attributing to changes in blood flow. The vasoactive substance endothelin1 is produced by vascular endothelial cells and serves as the most potent endothelialdependent vasoconstrictor by increasing intracellular calcium via an activated IP 3
pathway.

33

Vasoconstriction can also occur independently of the endothelium via the

actions of thromboxane A2, a cyclooxygenase (COX) pathway-derived prostanoid which
binds to TXA2 receptors directly on VSMC to initiate contraction.

91

The local vasodilatory response occurs in correlation with the bioavailability of the
potent vasodilator NO. NO production occurs when an isoform of nitric oxide synthase,
notably endothelial nitric oxide synthase (eNOS) converts L-arginine to L-citrulline.

18

Calcium dependent eNOS activation promotes the diffusion of NO into VSMCs to activate
the production of cyclic guanosine monophosphate (cGMP) and reuptake of intracellular
calcium. Additionally, eNOS activation independent of calcium induces NO action directly
upon the sarcoplasmic reticulum in VSMCs causing similar calcium reuptake

71

In turn, a

reduction in intracellular calcium reduces MLCK activity and results in vasodilation. These
mechanisms of endothelium-dependent vasodilation occur upon the binding of several
agonists on G-protein-coupled-receptors in the endothelium, such as acetylcholine to
muscarinic (M2) receptors. Additional mechanisms of vasodilation can result upon the
binding of the COX-derived prostaglandin I2 and various endothelium-dependent
hyperpolarizing factors to induce calcium reuptake via increased cAMP or VSMC
hyperpolarization respectively.

26

VSMC also enact an inherent myogenic response to

mechanical shear stress and increased transmural pressure via calcium channel

11

activation, promoting vasoconstriction and protecting downstream capillaries and organs
from high pressure effects.

52

Figure 3. Mechanisms of endothelium dependent vasodilation.

131

Vascular contractility can be assessed via in vitro measurements under
physiologically simulated conditions. Processes such as wire or pressure myography
allow the determination of vasoconstrictor and vasodilatory compliance within isolated
vessels under isometric or cyclic-stretched conditions.

70

Pharmacological manipulation

of the fluid environment within similar experimentations yields changes in vascular tone.
For example, the addition of phenylephrine, an alpha-1 adrenergic receptor agonist or
U46619, a TXA2 agonist contracts isolated aortic segments

57,108

Further addition of

acetylcholine or sodium nitroprusside in serially diluted concentrations induces
measurable vasorelaxation via endothelium-dependent and independent mechanisms
respectively. 6

12

2.3 Aortic Stiffening and Vascular Pathology
Cardiovascular disease remains the leading cause of morbidity and mortality
worldwide and can be widely attributed to vascular dysfunction. 60 Large elastic artery
stiffening, a subset of arterial dysfunction, describes a hallmark consequence of vascular
aging and disease. Upon normal aging or under pathological conditions, reductions in NO
bioavailability and alterations in aortic ECM structural remodeling promote endothelial
dysfunction and aortic stiffness.

35

Thus, the functional role of the aorta becomes

impaired, resulting in a decreased ability to dampen pulsatile blood flow, reducing
consistent peripheral perfusion.
The passive and active mechanical properties of the aorta dictate its ability to
function properly. Passive vascular compliance is dependent upon the composition of the
vessel’s ECM and is hindered with changes in wall structural components. 121 Increased
collagen deposition, decreased elastin formation, elastin fiber fragmentation,
infiltration

37

29

and AGE

alter vessel compliance to favor a stiffer phenotype under pathological

conditions. Collagen types I and III help provide the tensile strength of large elastic
arteries to reject wall deformation.
dissection

120

135

However, a human model of thoracic aortic

showed that increased expression of connective tissue growth factor

correlated with increased Type I and III collagen deposition within the aortic wall.
Increases in collagen as well as collagen disorganization within all three vascular
structural layers results in fibrosis that enhances arterial stiffness. Age or disease related
increases in vessel diameter further contribute to collagen remodeling.

28

This

compensatory mechanism reduces wall strain at the expense of reducing overall vessel
compliance.

13

Arterial stiffness is further characterized by reductions in total elastin content and
elastic fiber deformities. Matrix metalloproteinases facilitate the degradation of elastic
fibers under normal conditions but exacerbate vessel intrinsic stiffness under states of
already low elastin fiber content. Modifications such as calcification and fragmentation

23

result in functionally inept elastic fibers. Overall, decreases in functional elastin promote
the increased role of collagen in maintaining vessel integrity at the expense of vascular
compliance. Additionally, the post translational cross-linking modifications of AGEs
encourage vessel rigidity while influencing arterial active mechanical properties via
reductions in NO and downstream production of O 2-∙ radicals. 36
2.4 Stress and Depression
Stress is a comprehensive term that describes the body’s physiologic deviation
from homeostasis elicited by intrinsic or extrinsic stimuli (stressors), defined as real or
perceived threats, and the adaptive response required to return to a state of allostasis.
112

Stress elicits behavioral and physical changes necessary to promote survivability and

adaptation to alterations within the environment. Immediately, exposure to a stressor
induces an increased arousal, alertness, and analgesia.

92

Further, metabolic

upregulation including heightened gluconeogenesis and lipolysis with reduced cardiac
protein degradation ensures sufficient nutrient substrates in response to stressful stimuli.
42

Acutely, the stress response is highly adaptable and advantageous. However, chronic

exposure to stress results in overstimulation of the stress response mechanisms,
promoting dysregulation among neuroendocrine components and potential pathogenesis.
The stress response involves coordination and communication among neural,
endocrine, and effector organ systems. This response is characterized most prominently
14

by the activation of the autonomic nervous system and hypothalamic-pituitary-adrenal
(HPA) axis. 56 Distress signals sent to the hypothalamus act upon the autonomic nervous
system to induce a sympathetic “fight or flight” response.

122

Thus, sympathetic neural

signals act upon the adrenal medulla to release epinephrine and norepinephrine. These
catecholamines circulate throughout the blood stream and act systemically, increasing
heart rate, blood pressure, vascular tone, respiratory rate, and glucose transport while
suppressing basal functions. 102 Further, sympathetic outflow may aid in the regulation of
HPA axis components indicated by splanchnic nerve mediated potentiation of
corticosterone release in rats. 58
The HPA axis originates at the hypothalamus where corticotropin-releasing
hormone (CRH) is secreted to act upon the pituitary. CRH regulates pituitary release of
adrenocorticotropic hormone (ACTH) which further acts on the adrenal cortex to secrete
cortisol or corticosterone in humans and mice respectively. 51 Cortisol, under acute stress
conditions, stimulates gluconeogenesis and aids in the regulation of blood pressure.

45

Glucocorticoids further regulate inflammatory mediators by decreasing pro-inflammatory
cytokine secretion (TNF-α, IFN-γ) while increasing secretion of anti-inflammatory markers
(IL-10, IL-4).

84

Interleukin-6 (IL-6), a cytokine with pro and anti-inflammatory actions, is

the most abundant immune mediator released in response to acute stress. Interestingly,
IL-6 from brown adipose tissue was recently found to mediate stress-induced
hyperglycemia to facilitate “fight or flight” energy demands. 97
Under normal conditions, cortisol and catecholamines act upon upstream HPA axis
regulators including the hypothalamus, pituitary, and extrahypothalamic regulatory
centers. This process provides negative feedback and inhibition of the HPA response to
15

aid in regaining a state of allostasis. For example, glucocorticoids can inhibit ACTH
secretion to limit further glucocorticoid production, thus suppressing inductions of
gluconeogenesis and immune suppression.

44,66

However, under chronic stress

conditions, negative feedback mechanisms are removed causing an allostatic overload. 14
In turn, a myriad of detrimental physiologic consequences results through
neuroendocrine, immune, autonomic, and metabolic mediators.

83

Failure of inhibitory

neural mechanisms promotes increased sympathetic drive, increasing catecholamine
synthesis and basal circulation.

82

Dysregulated cortical function of the adrenals leads to

hypercortisolism and increases in pro-inflammatory cytokine mobilization such as TNF-α.
128

Chronic stress systemically hinders homeostasis, even disrupting the gastrointestinal

system as indicated in control mice transplanted with microbiota from chronically stressed
mice.

21

Overall, chronic stress exposure blunts the adaptive stress response to

homotypic stressors, whereas the introduction of heterotypic stressors elicits an
exacerbated response.

69

This hyperactive stress response harms the cardiovascular

system in various ways. Excessive sympathetic drive increases blood pressure and heart
rate while decreasing heart rate variability. Overactivation of the renin-angiotensinaldosterone system (RAAS) increases angiotensin II release, heightening vasoconstrictor
tone. 46 Further, stress-induced increases in pro-inflammatory, pro-thrombotic, and ROS

16

mediators promote vascular endothelial dysfunction. Together, chronic stress disrupts
vascular regulation to increase the risk of developing CVD such as atherosclerosis.

125

Figure 4. Acute and chronic hormonal response to stress. Corticotropic
Releasing-Factor (CRF), Adrenocorticotropic Hormone (ACTH), Sympathetic Nervous
System C(SNS) 14
Depression represents one of the top five causes of global disease burden,
increases the risk of cardiometabolic disease even within children.

95

3

and

Chronic stress

serves as a precursor to depression in humans and is confirmed via rodent studies of
17

stress-induced depressive behaviors. A widely utilized rodent model effective at inducing
a depressive phenotype, is the unpredictable chronic mild stress (UCMS) paradigm.
UCMS provides an accurate initiator of allostatic overload by promoting sensitization
while preventing habituation to stressors through a consistent and randomized stress
exposure. Its effects provide a depressive phenotype that impairs multiple organ systems,
indicated by increases in pro-inflammation within the hippocampus

129

to impairments in

spermatogenesis 130 in rodent models.
The effect of UCMS on cardiovascular health reveals impairments in
vasoregulatory components. Vascular dysfunction occurs in response to UCMS via
endothelial dysfunction indicated by reductions in endothelium-dependent middle
cerebral artery vasodilation in mice. Chronic stress induces vascular dysfunction via
decreases in NO through increases in oxidative stress and ROS generation.
2.5 Oxidative Stress
Oxidative stress plays a major role in physiologic homeostasis and describes the
balance between the production of ROS and antioxidants. ROS include radicals such as
O2-∙ and hydroxyl anions and non-radicals such as H2O2 and peroxynitrite. 104 Basal levels
of ROS are essential for cellular functioning, including signaling, growth maintenance,
defense mechanisms, and gene expression.

99,107

However, excessive accumulation of

ROS disrupts the balance between pro and antioxidant pathways, promoting
pathogenesis. Indeed, increased oxidative stress is a hallmark of chronic stress and
depression that correlates with several cardiovascular disease states. 76 ROS are derived
endogenously from aerobic mitochondrial respiration and exogenously via environmental
factors and several oxidative enzyme pathways. Included in these pathways are
18

nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, myeloperoxidases,
lipoxygenases, and xanthine oxidase (XO).
NADPH oxidase (NOX) is considered a predominant ROS generator
contributor of vascular dysfunction in both humans

32

and murine models.

100
126

and
NOX

enzymes constitute a family of transmembrane proteins that function primarily to produce
O2-∙ via electron transport from NADPH to oxygen. NOX enzymes are highly expressed in
immune responses, identified originally on neutrophils, and are associated with immunederived oxidative bursts.

106

The inflammatory role of NOX is indicated via attenuation of

TNF-α activation upon resveratrol treatment.

127

The RAAS system further can activate

NOX enzymes, emphasizing the potential for oxidative stress generation under conditions
of chronic stress.
Xanthine oxidoreductase (XOR) is distributed throughout the body but most
concentrated within the liver, where it is synthesized.

41

XOR is an enzyme involved in

purine catabolism that is comprised of a molybdenum-binding domain, two iron-sulfur
domains, and a flavin adenine dinucleotide (FAD) domain.

88

XOR exists in two forms,

xanthine dehydrogenase (XDH) and XO, and catalyzes the conversion of hypoxanthine
to xanthine to uric acid. 16 This conversion occurs at the molybdenum site whereas NAD +
or O2 reduction occurs at the FAD site. Under normal physiologic conditions XDH
facilitates the reduction of NAD+ to NADH. However, under diseased states of hypoxia or
ischemia, XDH is converted to XO in which O2-∙ and H2O2 production is favored at the
FAD domain.

89

Thus, under the chronic stress phenotype, XO activity is predominant,

increasing O2-∙ expression. XO is able to bind to the surface of vascular endothelial cells

19

via heparin sulfate glycosaminoglycans, 1 emphasizing its role in oxidative stress-derived
vascular dysfunction.

Figure 5. XOR-Catalyzed Reactions.16
Endothelial dysfunction is characterized via a reduction in the potent vasodilator
NO. An accumulation of vascular oxidative stress promotes this dysfunction by
decreasing the bioavailability of NO via its sequestration by O2-∙ anions. XO or NOXderived O2-∙ reacts with available NO to produce peroxynitrite.

38

Peroxynitrite can then

oxidize L-arginine and tetrahydrobiopterin (BH4), the substrate and cofactor of functional
eNOS. This uncoupling of eNOS alters its function to inhibit NO production and favors
further O2-∙ formation.

105

In turn, increases in O2-∙ elevate peroxynitrite levels, creating a

bidirectional cycle of oxidative stress production, eNOS uncoupling, and NO reduction.

20

Chronic stress promotes vascular depression by fueling this cycle. Thus, potential for both
functional and structural vascular impairments results.

Figure 6. eNOS Uncoupling. 114

2.6 Nitrite and Therapy
NO is a diatomic gaseous free radical that functions across several physiologic
systems.

63

Its signaling role is involved in immune,

cardiovascular functioning.

72

34

neural,

61

gastrointestinal,

55

and

Most notably, NO is a potent vasodilator that regulates

vascular tone, and its abundance correlates with vascular endothelial health. In fact,
oxidative stress and inflammation-induced reductions in NO promote vascular endothelial
dysfunction. Thus, therapeutics designed to target NO bioavailability and the mechanisms
of NO production are essential in addressing vascular dysfunction.
Bioactive NO contains an unpaired electron that facilitates its chemistry as a highly
reactive binding and signaling molecule.

77

NO has a short half-life, is readily consumed,

and thus must be continually produced to serve its biological functions. Production of NO
21

occurs through two main pathways: activation of eNOS and the nitrate-nitrite-NO pathway
indicated in Figure 7.

12

Traditionally, activation of NOS within the vascular endothelium

converts L-arginine to L-citrulline and produces NO. More recently discovered is the
nitrate-nitrite-NO pathway, in which commensal bacteria in the mouth reduce nitrate to
nitrite that is deposited within the circulation until final conversion to active NO by nitrite
reductases in vascular tissue.
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Crossover exists between the two mechanisms as

eNOS-derived NO can oxidize to nitrate by heme proteins and fuel further NO production
via the latter pathway.

19,115

physiologic

nitrate-nitrite-NO

pH,

the

Whereas eNOS functions under aerobic conditions at
pathway

can

produce

pathophysiologic conditions of hypoxia and lower pH values.

93

NO

under

the

Therefore, the nitrate-

nitrite-NO pathway provides a unique target mechanism of therapeutic intervention in
vascular endothelial dysfunction. In fact, nitrate and nitrite supplementation have provided
insight in the amelioration of various cardiovascular diseases.

Figure 7. Pathways of NO Generation
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Nitrate is obtained within humans via dietary inclusion and through the oxidation
of NO. Nitrate-rich cruciferous vegetables and certain roots (i.e. beetroot) are the
predominant source of nitrate intake. Consumption of these foods results in nitrate
absorption via the upper GI tract and sialin-mediated transport into the salivary glands
from the circulation.

123

Within the oral cavity, and in the presence of saliva and oral

microbiota, nitrate is reduced into nitrite then absorbed into the circulation. Nitrite can then
be stored within tissue beds until reduction to NO is warranted. Whereas oral bacteria
have been deemed necessary for the conversion of nitrate to nitrite in mammals, some
evidence suggests an alternative mechanism of nitrate reduction within mammalian
species. This was hypothesized upon increases in circulating nitrite levels despite
complete eradication of salivary nitrite with mouthwash intervention in humans.

59

Mammalian nitrate reduction independent of the oral microbiota is thus suggested via the
actions of the enzyme XOR. 17
Nitrite similarly is obtained within humans via the oxidation of NO, as well as
consumption of nitrate and nitrite-rich foods, the latter to a lesser extent. Nitrite, as
previously mentioned, is produced primarily via the oral reduction of nitrate. Transport of
nitrite then occurs through the GI system (direct gastric acid reduction to NO)

63

and

circulation. Unlike nitrate, nitrite can be readily reduced to active NO via several
mammalian molybdenum-containing oxidase enzymes. Predominantly, XOR facilitates
the conversion of nitrite to bioactive NO.
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While XO-mediated increases in O2-∙ anion promote vascular endothelial
dysfunction via the sequestration of bioavailable NO, a dual role or compensatory
mechanism occurs under similar conditions in which XO catalyzes nitrite to NO at its
23

molybdenum site. 68 XO expression is increased under hypoxic and inflammatory disease
conditions, suggesting a target for O2-∙ inhibition or NO enhancement. Nitrite is reduced
at the XO molybdenum cofactor directly via xanthine or indirectly via electron flow through
the FAD site provided by NADH.

17

O2 fueled O2-∙ generation functions competitively with

direct nitrite reduction. However, the latter mechanism of indirect nitrite reduction to NO
provides a shift in O2-∙ generating XO indicated in the figure below.

17

Figure 8. Nitric oxide generating shift in xanthine oxidase.
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Thus, under conditions of increased available nitrite and in the presence of NADH
substrate, XO will effectively favor NO production and subsequently reduce the formation
of O2-∙ and H2O2. The role of XO-mediated NO formation is confirmed in studies indicating
a prevention of supplemental nitrite-induced benefits in murine models upon XOR
inhibition via allopurinol.

13,22

Further, studies investigating eNOS deficient mice

discovered heightened XOR expression and activity as well as comparative levels of
plasma nitrate and nitrite to wild-type animals.

78,94

While transgenic models of XOR are
24

lacking, recent improvements have been made in specific XO knockouts, providing insight
for further experimentation. 103 This mechanism and therapeutic target of an XO-mediated
nitrate-nitrite-NO pathway is especially important within the context of vascular
dysfunction in which increased oxidative stress and decreased NO bioavailability facilitate
pathology. The potential role of nitrite in ameliorating these consequences is key and is
supported in various instances of supplemental treatment in cardiovascular diseases.
Recently, investigations have pointed to skeletal muscle as a site of nitrate and
nitrite storage, transport, and reduction into active NO. Support for hypothesis has grown
indicating nNOS-derived NO as a fuel for skeletal muscle nitrate storage.

59

This was

suggested due to decreases in nitrate levels within an nNOS-knockout murine model.

96

Further, it has been shown that skeletal muscle can play an active role in nitrate/nitrite
reduction to bioactive NO. Here, XOR is predicted to facilitate this conversion mimicking
its role in the liver. This was evident in findings of nitrate and nitrite reduction to NO at
physiologic pH that was enhanced under acidic pH and inhibited via allopurinol but not LNAME treatment.
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Thus, this suggests a critical involvement of XOR without the

activation of NOS, furthering the role of XOR in the nitrate-nitrite-NO pathway.
Historically, nitrate and nitrite have been utilized in the preservation of foods,

11

as

an intervention in cyanide poisoning, 5 and within the immediate treatment of angina via
nitroglycerin. 85 Treatment with nitrate and nitrite has gained significance within the scope
of cardiometabolic disease, notably due to their role in protecting against ischemia
reperfusion (IR) injury within the heart. IR human studies have confirmed sodium nitriteinduced preservation of endothelial function via brachial flow mediated dilation
assessments.

54

Further, murine models of IR support theories of XOR-mediated
25

increases in NO bioavailability upon sodium nitrite treatment.

48

The benefits of nitrate

and nitrite supplementation in ischemic conditions have been reported in hepatic, 22 renal,
118

skeletal muscle, 62 and various vascular models.
Investigation into treatment with nitrate and nitrite has highlighted their

effectiveness in managing or reversing several cardiovascular diseases. Additional
studies have since indicated an effective dose-dependent rise in plasma nitrite levels
upon supplementation with both dietary and inorganic nitrate via drug and beetroot juice
respectively.

64

Similar rises in plasma nitrite are observed upon direct treatment with

sodium nitrite. Recently, acute dietary nitrate supplementation revealed decreases in
systolic blood pressure in young and old adults, with benefits most prominent in older
individuals.

20

In a mouse model of angiotensin II-induced hypertension, decreases in

systolic blood pressure, nitrotyrosine formation, and endothelial dysfunction have been
observed upon sodium nitrite implementation, suggesting a therapeutic intervention of
nitrite in vascular disease.

47,73

Models of atherosclerosis, diabetes, cerebrovascular

disease, and aging further highlight the mechanisms of nitrite-induced therapy in vascular
dysfunction. 4,40,109,110
For example, extensive investigation within the role of sodium nitrite treatment in
the vascular health of aging mice has been performed by the labs of Fleenor and Seals.
Aged mice display phenotypes of vascular endothelial dysfunction and increased arterial
stiffness. 15,43 Interestingly, treatment with sodium nitrite has been found to reduce aortic
pulse wave velocity (PWV) and pro-inflammatory cytokine production within aging mice.
37,110

Further, nitrite supplementation has reversed O2- production, nitrotyrosine formation,

NADPH oxidase expression, and AGE formation to young control levels in old mice.
26

37,109,110

These findings emphasize the mechanisms by which sodium nitrite

supplementation exerts its effects. Reductions in PWV confirm decreases in arterial
stiffness mediated by increased AGE formation. The normalization of O 2- and
nitrotyrosine levels suggest previous oxidative stress-derived decreases in NO
bioavailability. Thus, these investigations confirm the role of nitrite in preserving the
functional and structural health of certain elastic arteries and resistance vessels in a
murine aging model. Additionally, similar research has been performed in human patients,
establishing nitrite as a therapeutic in restoring brachial flow mediated dilation and carotid
artery beta-stiffness index in older individuals.

31,53

Figure 9. Intervention of exogenous nitrite in the mechanisms of vascular dysfunction 109

Supplementation with sodium nitrite as opposed to exogenous nitrate is
advantageous in various ways. Nitrite involves a single conversion to bioactive NO, thus
27

ensuring a direct treatment response. Further, nitrate reduction is dependent on the
function of the microbiota within the oral cavity that can be altered upon antibiotic usage
and oral hygiene practices. Within the paradigm of chronic stress, similar vascular
phenotypes are observed as in previously mentioned models of vascular dysfunction
mended by nitrite treatment. Chronic stress induces uncoupled eNOS, NOX, and XOinduced increases in oxidative stress and subsequent reductions in NO. Increasing nitrite
levels favors the targeting of XO, providing a unique mechanistic manipulation of NO
production and potential reversal of endothelial dysfunction. Thus, sodium nitrite provides
a direct and preferred route to increase NO bioavailability that limits technical
complications and favors vascular endothelial health.

28

Chapter 3

Methods
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3.1 Animal Model
Male and Female (n=11-15 per group) C57Bl/6 mice were obtained from the
Jackson Laboratory and arrived at West Virginia University Health Sciences Center at 16
weeks of age. Mice were individually housed in OLAR facility throughout experimentation
and were aged 2 additional weeks prior to protocol. Mice were divided into one of four
groups: 1) control, 2) UCMS, 3) control+nitrite, 4) UCMS+nitrite. At 18 weeks of age,
respective mice began chronic stress treatment and/or an 8-week nitrite supplementation
(50mg/L) in drinking water. Control animals were transported alongside mice undergoing
UCMS paradigm daily. All mice received chow and water ad libitum, and protocols
received approval from the West Virginia University Health Sciences Center Animal Care
and Use Committee prior to experimentation.
3.2 UCMS Protocol
The UCMS Protocol was developed to induce depression-like behaviors in
rodents. This approach is the most appropriate model for clinical depression in rodents
and mimics human-like depressive behaviors, including anhedonia and learned
helplessness. During the UCMS protocol, mice were housed individually and randomly
exposed to the following mild environmental stressors for 7 hours each day, 5 days per
week, over an 8-week course:
1. Damp bedding – 10 oz. of water was added to each standard cage 25
2. Bath – all bedding was removed and ~0.5 inches of water were added
to the empty cage. Water temperature was at room temperature, ~24C
3. Cage tilt – cage was tilted to 45 without bedding
4. Social stress – each rat was switched into a cage of a neighboring rat
5. No bedding – all bedding was removed from the cage
30

6. Alteration of light/dark cycles – turning the lights off/on in random
increments for a scheduled period

Figure 10. Graphical representation of UCMS paradigm
3.3 Behavioral Assessments
3.3.1 Coat Scores
To validate the unpredictable chronic mild stress paradigm, animal coat scores
were assessed at 8 anatomical sites (head, neck, back, stomach, tail, forelimbs,
hindlimbs, and genitals). Scoring was binary with 0 indicating “clean”, and 1 equating to
“dirty”. The 8 individual site scores were added together to equal the coat score.
3.3.2 Sucrose Splash
To provide further validation of the behavioral effects of UCMS implementation,
mice underwent sucrose splash testing in which animals were placed in an empty cage
and sprayed with 10% sucrose solution on the back area. After sucrose exposure, latency
to lick in seconds and number of licks were recorded over a five-minute period.
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3.5 Aortic Contractility
At 26 weeks of age, mice were anesthetized with isoflurane and euthanized via
cardiac puncture and exsanguination. Mice underwent perfusion with Phosphate Buffered
Saline containing Heparin. Thoracic aortas were carefully excised, cleaned of excess
perivascular adipose tissue, and cut into 2mm rings. Aortic rings were gently mounted on
2mm horizontal pins within myograph chambers (model 620M, DMT, Denmark)
containing 5mL Krebs Henseleit buffer at 37°C and bubbled with 95%CO 2 and 5%O2.
Vessels equilibrated for 10 minutes at zero tension then were incrementally stretched by
0.25g until a resting tension of 1.0g was reached.
After an acclimation of 30 minutes at resting tension, aortas were challenged via
KCl (60 mM) addition to test for vessel viability. To develop tone, vessels were
precontracted with the thromboxane A2 agonist U46619 (7.5 nM) prior to vasodilatory
drug responses. Following preconstriction, endothelium-dependent dilation was
measured via tension change (g) after cumulative addition of increasing concentrations
of methacholine (MCh; 10-9M to 10-5M). Three consecutive 50mL Krebs Henseleit washes
were performed between drug responses. Additional MCh responses were measured
after 30-minute incubations with the NO synthase inhibitor L‐NAME (10-4M) Endotheliumindependent dilation was measured via tension change (g) upon cumulative addition of
increasing concentrations of sodium nitroprusside (SNP; 10 -9M to 10-5M).
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Dose response data is presented as a percentage. Dilation was calculated as
%relaxation for each dose of MCh/SNP from the following equation:

where z = tension after U46619 (7.5 nM), x = tension following a given dose of MCh/SNP,
and y = baseline tension. Contractile KCl response was calculated as tension change
from the following equation:

where z = tension after KCl (60 mM) and x = resting tension.
3.6 Intrinsic Stiffness
Thoracic aortas were isolated, excised, cleaned of surrounding PVAT, and cut into
2mm rings within a dissecting dish containing PBS solution. The clear dissecting dish was
placed onto a dark background fitted with a scientific metric ruler. Using forceps, individual
aortic rings were oriented under a microscope to obtain images of

Figure 11. Aortic ring measurements of wall thickness and vessel length
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vessel wall thickness and length. Images were processed and set-to-scale to determine
wall thickness and vessel length measurements using ImageJ software (1.53a).
Aortic rings were carefully mounted onto 200um horizontal pins in a myograph
containing 37°C Ca2+ and Mg2+ free PBS solution. Micrometer readings were recorded
when pins were almost touching and positioned at vessel walls to determine gap distance.
Internal circumference and diameter were calculated via the following equations:

where d = pin size (μm), x = gap distance (μm), and IC = internal circumference.
Vessels acclimated in PBS for 30 minutes then underwent a 1mm luminal
displacement for 3 minutes and return to non-stretched baseline. Ring tensions were
zeroed then set to 1mN force for 3 minutes. Micrometer readings were recorded at 1mN.
Micrometers were displaced by 50 μm every 3 minutes until a yield point as indicated by
a decrease in tension.
Stress and strain measurements were used to determine intrinsic stiffness (elastic
modulus) and were calculated via the following equations:

where t = one-dimensional stress, λ = strain, L = one-dimensional load applied (force in
mN), H = wall thickness, D = length of vessel, Δd = change in diameter, and d(i) = initial
diameter. Collagen-dependent intrinsic stiffness was determined by the linear regression
of the last 4 data points prior to vessel fatigue.
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3.7 Pulse Wave Velocity
Mice underwent anesthetization with inhaled isoflurane and body temperature was
maintained at 37°C throughout the procedure. A 15-MHz linear-array transducer and
color-flow Doppler probe (VisualSonics Vevo 2100) was used to visualize the common
carotid artery. Sites were identified via Doppler to obtain pulse waveforms including the
aortic arch and upstream carotid bifurcation. Signals were recorded at 200m/s over
multiple cardiac cycles. Analysis was conducted on imaging workspace 3 in which carotid
distance (in mm) was measured between Doppler sites. Further, pre-ejection time (Rwave of echocardiogram to foot of Doppler signal) was measured at each site (in ms).
Pulse wave velocity was calculated by the following equation,

in which D indicates the distance between the aortic arch and carotid bifurcation and T is
the difference in measured pre-ejection times of the respective sites.
3.8 Collagen/Elastin Content
3.8.1 Staining Protocol
Following terminal procedure, abdominal aortas were excised, formalin fixed, and
stored in 95% ethanol. Fixed aortic tissue was embedded in paraffin and prepared into 5
μm cross-sections. Paraffin sections were stained with hematoxylin and eosin, then
immunohistochemical staining was performed with Collagen I (1:100, ab21286) for
collagen analysis. Elastin staining was performed with Van Gieson elastin kit (SigmaAldrich HT25A-1KT) on respective paraffin sections. Primary antibodies were incubated
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for 10 minutes and rinsed with TBS buffer. Slides were subsequently dehydrated, coverslipped, and stored for 48hrs prior to analysis.
3.8.2 Image Analysis and Quantification
Digital

photomicrographs

were

obtained

using

a

Nikon

Eclipse

E800

photomicroscope, and quantification was performed with ImageJ software (1.53a). The
adventitial and medial layers for each collagen I stained sample were quantified
independently and summed to determine whole vessel collagen I expression. The medial
layer of alpha elastin stained samples was utilized to determine elastin content. Values
were calculated as percent of total layer area.
3.9 Data/Statistical Analysis
All data are represented as means ± standard error or standard deviation. Data
analysis and graphing were conducted using GraphPad Prism 8 software (GraphPad
Software, Inc.) and p<0.05 was set as the indicator for statistical significance. Data were
first assessed for normal distribution followed by appropriate statistical testing. One-way
ANOVA analysis was used to determine group effects of stress and/or nitrite treatment.
Repeated measure ANOVA analysis was implemented for acute drug treatment effects
and dose responses within aortic reactivity data. The Holm-Sidak post-hoc test was used
to determine group differences where appropriate.
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Results
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4.1 Animal Characteristics
Table 1 indicates measurements of final bodyweight, adrenal weight, and average
food and nitrite-supplemented water consumption among animals. No differences in body
weight (n=4-9 per group) were observed across the four groups. Implementation of the
UCMS paradigm resulted in a nonsignificant trend of increased adrenal weight (n=9-12
per group) within male mice that was unchanged upon sodium nitrite supplementation.
Similarly, a trend of increases in adrenal weight (n=5-9 per group) were observed within
chronically stressed female mice that were unchanged upon sodium nitrite treatment. All
animals consumed the same average quantity of food throughout the duration of the study
(n=11-15 per group). Further, nitrite intake among animals was consistent on average
within treated groups (n=11-12 per group).
Table 1. Animal Characteristics.
Control

Control+NO2-

UCMS

UCMS+NO2-

Final Bodyweight (g)

26.8 ± 1.1

27.1 ± 0.6

24.8 ± 0.9

25.2 ± 0.8

Daily Food Intake (g)

4.1 ± 0.4

4.0 ± 0.2

4.2 ± 0.1

3.9 ± 0.2

NA

0.23 ± 0.01

NA

0.23 ± 0.01

Adrenal Weight (mg)

4.44 ± 0.40

4.16 ± 0.51

5.61 ± 0.47

5.39 ± 0.42

Normalized Adrenal Weight (AU)

1.70 ± 0.22

1.58 ± 0.23

2.28 ± 0.23

2.22 ± 0.22

Daily Nitrite Intake (mg)

Values are mean ± SEM. (n=4-15 per group). *p<0.05
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4.2 Effect of UCMS and Nitrite Supplementation on Behavior
To determine the behavioral consequences of the UCMS paradigm, coat scoring
and sucrose splash testing was performed. Figure 12 indicates the behavior testing
results from both sucrose splash testing (n=14-20 per group) and coat scoring (n=17-21).
Panel A reflects total number of licks following sucrose exposure and reveals a decrease
in licks in chronically stressed mice (p<0.05) that was not ameliorated with sodium nitrite
treatment. Treatment produced no differences within the control group. Panel B shows
latency to lick in seconds and describes an increase in time-to-lick in chronically stressed
mice (p<0.05). Sodium nitrite treatment had no effect on control or UCMS groups. Panel
C indicates coat scoring in which chronic stress induced an increase in coat score
(p<0.05) that was unchanged upon sodium nitrite treatment. Sodium nitrite treatment
presented no effects on control group.
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Figure 12. Behavioral assessments of UCMS and sodium nitrite treatment. A) Sucrose
splash testing licks. B) Sucrose splash testing latency-to-lick. C) Coat scoring. Values
are mean ± SEM. (n=14-21 per group). *p<0.05

4.3 Effect of UCMS and Nitrite Supplementation on Aortic Reactivity
Figure 13 highlights the amelioration of chronic stress-driven impairments in aortic
endothelial function upon treatment with sodium nitrite. Endothelium-dependent dilation
to methacholine (MCh), represented by percent dilation following U46619 precontraction,
was impaired 16% in chronically stressed mice (p<0.05) compared with control animals
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(87 vs 71%). Supplementation with sodium nitrite rescued dilation to MCh in chronically
stressed mice while having no effect in control animals (p<0.05) (83 vs 80%).

Figure 13. Aortic endothelial vasodilatory response to increasing concentrations of
methacholine. Values are mean ± SD. (n=11-15 per group). *p<0.05 UCMS+NO 2- vs
UCMS, ^p<0.05 Con vs UCMS.

Endothelium-independent dilation to sodium nitroprusside was assessed as
represented in Figure 14. Here, dilation to increasing concentrations of SNP resulted in
no significant differences among groups. Further, dilation to SNP was not influenced by
supplementation with sodium nitrite.
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Figure 14. Aortic vasodilatory response to increasing concentrations of sodium
nitroprusside. Values are mean ± SD. (n=11-15 per group). *p<0.05 UCMS+ NO 2- vs
UCMS, ^p<0.05 Con vs UCMS.

Maximal endothelial-dependent dilation to MCh (10 -5) in the presence and absence
of the eNOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) is indicated in Figure
15A. Incubation with L-NAME elicited a reduction in dilation across all groups regardless
of treatment (p<0.05). Subtracting L-NAME incubated MCh dilation from MCh dilation
values allowed for determination of NO-dependent dilation measurements. Indicated in
Figure 15B, NO-dependent dilation was reduced in chronically stressed mice (p<0.05)
compared to control animals. Supplementation with sodium nitrite restored NOdependent dilation in chronically stressed mice and had no effect on control animals
(p<0.05).
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Figure 15. A) Maximal endothelium-dependent dilation in presence of L-NAME. Values
are mean ± SD. (n=11-15 per group). *p<0.05 vs L-NAME. B) Nitric oxide (NO)
dependent vasodilation. Values are mean ± SD. (n=11-15 per group). *p<0.05 UCMS+
NO2- vs UCMS, *p<0.05 Con vs UCMS.
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Figure 16 indicates the mechanistic role of xanthine oxidase (XO) in endothelial
dysfunction via acute incubation with the XO inhibitor febuxostat. Acute incubation of
febuxostat restored maximal endothelium-dependent dilation to MCh in chronically
stressed mice (p<0.05). Incubation with febuxostat had no effect on control or nitritetreated groups.

Figure 16. Aortic endothelial response with acute febuxostat treatment. Values are
mean ± SD. (n=11-15 per group). *p<0.05.
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4.4 Effect of UCMS and Nitrite Supplementation on Aortic Stiffness
Stiffness assessments first included the quantification of the aortic structural
proteins, elastin, and collagen. Figure 17 indicates the quantification of medial elastin
within the abdominal aorta. No differences were observed in medial elastin content
between groups regardless of nitrite treatment. Figure 18 indicates the quantification of
medial and adventitial collagen-1 content in the abdominal aorta. Similarly, no differences
were observed in medial or adventitial collagen content between groups regardless of
nitrite treatment.

Figure 17. A) Elastin content in media of abdominal aorta. B) Representative images
displaying medial aortic elastin content. Values are mean ± SEM. (n=4 per group).
*p<0.05
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Figure 18. A) Collagen content in media and adventitia of abdominal aorta. B)
Representative images displaying medial and adventitial aortic collagen content. Values
are mean ± SEM. (n=7-8 per group). *p<0.05

Additionally, the elastic modulus, a measurement of aortic intrinsic mechanical
stiffness (Figure 19) yielded no differences among groups and treatment status. Further,
measurements of active large elastic artery stiffness via pulse wave velocity (Figure 20)
returned no significant differences regardless of group or treatment.
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Figure 19. A) Aortic intrinsic stiffness. B) Collagen-dependent aortic intrinsic stiffness.
Values are mean ± SD. (n=4 per group). *p<0.05
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Figure 20. Large elastic artery pulse wave velocity measured in common carotid artery.
Values are mean ± SD. (n=6 per group). *p<0.05.
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Chapter 5

Discussion
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5.1 Sodium Nitrite Treatment and UCMS Paradigm Validation
Chronic stress and depression represent major risk factors for the development of
cardiovascular disease, contributing to morbidity and mortality worldwide.

14

Chronic

stress has been previously documented as a contributor in the development of vascular
disease via functional alterations in endothelial regulation and proposed structural
remodeling that promotes stiffness.

7,10,30

Sodium nitrite supplementation is a novel

treatment that is proven safe and effective in models of aging and various CVD.
The purpose of this thesis was to elucidate the functional and structural effects of
sodium nitrite treatment in chronically stressed mice. Our findings indicate a restoration
of aortic endothelial dysfunction upon sodium nitrite treatment due to increases in
bioavailable NO and decreases in O2-∙ generation via utilization of the XOR-mediated
nitrate-nitrite-NO pathway. Further, we report no alterations in large elastic artery stiffness
associated with chronic stress or sodium nitrite treatment. Thus, we provide evidence
suggesting sodium nitrite treatment as a beneficial therapeutic in vascular endothelial
dysfunction.
The UCMS paradigm has been previously documented in our lab and others,

15,39

to induce biologic and behavioral decrements within rodent models. Previous findings
have indicated increases in adrenal weight within chronically stressed mice.

7,10,30

However, our current results suggest a nonsignificant increase in bodyweight-normalized
adrenal weight in chronically stressed mice that remains upon sodium nitrite treatment.
Further, daily food intake among all animals and nitrite intake among treated animals were
the same across groups indicating sufficient nitrite exposure. Therefore, differences in
measured parameters among groups and treatment status are determined independent
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of bodyweight and food consumption. UCMS has been shown to induce depressive
behavioral complications such as anhedonia. 15 Our findings provide behavioral validation
of the UCMS paradigm in coat scoring and sucrose splash testing. Chronically stressed
mice expressed increased latency-to-lick and fewer licks overall, consistent with
depressive behavior. Further, coat scores, an alternative measurement of anhedonia
were higher in chronically stressed mice. Sodium nitrite treatment failed to ameliorate
changes in depressive behavior, suggesting an adequately stressed phenotype within the
UCMS and UCMS+Nitrite treated groups.
5.2 Sodium Nitrite Treatment Restores Endothelial Function in Chronically
Stressed Mice

Previous work has established impairments in endothelial vascular function due to
chronic stress exposure in rodent models.

7,9,30

Here, we show a consistent decrease in

MCh-mediated endothelial dependent dilation in our chronically stressed mice that is
ameliorated upon treatment with sodium nitrite. Though this finding is novel within our
model of chronic stress, it agrees with similar findings of restored endothelial function due
to sodium nitrite supplementation in mouse models of aging and hypertension.

87,110

Further, we confirm dysfunction at the endothelial level without VSMC influence via our
reporting of no differences in SNP-mediated endothelium independent dilation.
We further divulge the mechanisms associated with chronic stress-induced
endothelial dysfunction and mitigation via sodium nitrite treatment. Reduced NO
bioavailability and increased oxidative stress generation are hallmarks of vascular
endothelial dysfunction. We confirm a reduction in NO-dependent dilation in chronically
stressed mice via acute incubation with L-NAME that is restored upon sodium nitrite
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supplementation. We have previously shown increases in oxidative stress generation due
to chronic stress exposure.

7,9,30

Further, recent unpublished data suggests the

involvement of XO as a main generator of chronic stress-induced oxidative stress and
mediator of vascular endothelial dysfunction in elastic and resistance vessels. Here, acute
incubation with the XO inhibitor febuxostat rescued endothelial dependent dilation in
chronically stressed mice, confirming a role of XO-mediated oxidative stress formation.
Oxidative stress-induced decreases in NO bioavailability inhibit the proper function
of eNOS within the vascular endothelium. O2-∙ anions produced by XO sequester already
decreasing levels of NO to form peroxynitrite. Oxidation of the eNOS cofactor BH 4 by
peroxynitrite further facilitates the uncoupling of eNOS. Dysfunctional eNOS then shifts
in its production of NO to further the generation of O2-∙ radicals. Thus, a cycle of oxidative
stress generation, eNOS uncoupling, and NO reduction results. Here, we suggest
reductions in NO bioavailability and increased O2-∙ anion generation via the oxidant
enzyme XO, due to resulting vascular endothelial dysfunction within our chronically
stressed mice. We can infer that the mechanisms of eNOS uncoupling are present within
our current model. However, supplementation with sodium nitrite restored endothelium
dependent dilation via increases in NO bioavailability independent of dysfunctional eNOS.
Thus, NO generation associated with sodium nitrite supplementation is consistent with
activation of the XOR mediated nitrate-nitrite-NO pathway.

2

The current data indicates

that nitrite treatment likely fueled an XOR molybdenum switch within our chronically
stressed mice that favored bioactive NO generation, limiting O 2-∙ anion formation. A
bypassing of the dysfunctional pathway of eNOS-mediated NO production allowed for
increases in the bioavailability of NO via the alternative nitrate-nitrite-NO pathway. Thus,
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activation of this mechanism provides two separate benefits: reduction of O 2-∙ generation
due to an XOR molybdenum switch and increase in NO bioavailability due to XORmediated conversion of nitrite to active NO. These findings provide support to indicate
sodium nitrite treatment as a therapeutic for vascular endothelial function that mitigates
oxidative stress and restores NO mediated endothelial dilation.
5.3 Chronic Stress and Nitrite Treatment Induce No Alterations in Large Elastic
Artery Stiffness

Whereas we initially hypothesized alterations in large elastic artery stiffness due
to chronic stress, the data suggests no increases in stiffness within chronically stressed
mice. These results disagree with previous findings of increased intrinsic stiffness within
a rat model;

30

However, our current findings remain consistent across several

parameters. Intrinsic mechanical stiffness measurements within the thoracic aorta
revealed no differences among groups regardless of chronic stress or nitrite exposure.
Further, pulse wave velocity measurements within the common carotid artery expressed
similar findings. Therefore, no increases in passive or active large elastic artery stiffness
were observed within our chronically stressed mice.
Structural remodeling within the large elastic arteries, including collagen-1
deposition and alpha-elastin reduction and fragmentation, is the main promoter of
vascular stiffness. Investigation into the structural profile of the abdominal aortae revealed
no alterations in medial or adventitial collagen deposition or medial elastin content due to
chronic stress or nitrite treatment. Whereas sodium nitrite supplementation has been
shown to decrease aortic stiffness in a mouse model of aging, the mechanisms
highlighted involve the formation of AGE.
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AGE formation is associated with aging,
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whereas our chronically stressed mice are young animals. Therefore, the absence of AGE
formation within chronically stressed mice may account for the absent increase in aortic
stiffness that agrees with our measured structural parameters.
5.4 Nitrite Treatment as a Therapeutic Intervention in Vascular Dysfunction
Nitrite supplementation has been previously documented as a beneficial mediator
of various cardiovascular diseases. Notably, IR injury studies first introduced the
therapeutic potential of sodium nitrite via its ability to increase NO bioavailability. Further
investigations including our own indicate sodium nitrite as an effective therapy in reducing
oxidative stress production in rodent models of aging,

109,110

hypertension, 87 and chronic

stress. 10,30 We have shown that treatment with sodium nitrite preserves aortic endothelial
function through reductions in oxidative stress and restoration of NO bioavailability.
Separate murine models of aging and hypertension
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further suggest a therapeutic

potential for sodium nitrite via similar mechanisms of ROS/NO balance. Treatment with
sodium nitrite has been proven safe and effective throughout murine models.
Recently, further insight has been gained into the clinical implications for nitrite
therapies. For example, Seals and colleagues have revealed novel findings of increases
in flow-mediated dilation in human subjects following 12 weeks of 80mg/day nitrite
supplementation. Further, nitrite-mediated reductions in oxidative stress marked by
nitrotyrosine abundance suggest mechanistic insight into both human and murine models
of vascular endothelial dysfunction.

37,110

Reverse translational findings indicate similar

safety and efficacy in sodium nitrite treatment towards humans compared to murine
models such as our own, indicating improvements in endothelial dependent dilation.
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Additionally, previous work suggests improvements of carotid artery medial thickness
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and stiffness within a clinical population following treatment with sodium nitrite.
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Though

additional research is required, these early translational findings suggest sodium nitrite
treatment as a safe and effective clinical mitigator of vascular disease.
5.5 Limitations

Further, the current findings fail to provide specific identification in the activation
levels of the nitrate-nitrite-NO pathway. Additional fluorescent markers of nitrite and
circulating NO levels would reinforce the mechanistic findings of the current study. Due
to small tissue availability of the thoracic aorta, samples were prioritized for reactivity data
instead of protein quantification. Little sample remained for further investigation, and
optimization protocols for western blotting provided time constraints with protein analysis.
Since then, thoracic aorta protein validation has been completed and future research
should include protein quantification via western blotting to assess eNOS phosphorylation
and XO activity, providing additional mechanistic insight.
Stiffness assessments provided consistent findings with structural measurements.
However, due to inclusion of the elastic modulus protocol when reactivity was already
underway, stiffness measurements were not obtained in total for the female cohort. Thus,
female sample size was significantly decreased and was omitted. Additionally, collagen
analysis with our chosen antibody provided collagen-1 staining that provided challenges
in distinguishing collagen content with nuclei and adventitial tissue staining. This was
mediated via adoption of an alternative analysis. For future experimentation, staining with
Masson-Trichrome would provide clearer staining for further collagen analysis.
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5.6 Future Directions
After experimentation, we did not observe any significant changes in large elastic
artery stiffness as previously hypothesized. This was likely due to the young age of our
mice as it has been documented that structural remodeling occurs with aging and aortic
stiffness correlates with AGE formation. Further, because stress exposure typically
occurs throughout life rather than within a set period, the implementation of UCMS into
an established mouse model of aging would provide additional translatable information.
Thus, an experiment would be designed in which the UCMS paradigm would be
implemented in already aging mice. In turn, the addition of aging within the current model
would likely provide instances of vascular structural remodeling and increased stiffness.
As stiffness is associated with aging, the role that UCMS and aging play individually in
the development of vascular stiffness would need to be teased out. Further, comparing
vascular stiffness measurements between old mice versus old and stressed mice would
be essential in determining the potential exacerbating effects of chronic stress on aging.
Lastly, sodium nitrite supplementation would be included, similar to the current
experiments, to provide a potential therapeutic to mitigate vascular stiffness.
Additionally, to aid in mechanistic insight into our conclusions of XO-mediated
nitrite conversion to NO, I propose the inclusion of the XO-inhibitor drug febuxostat within
the drinking water of our current design. Here, we would implement a dual drug exposure
of sodium nitrite and febuxostat alongside inclusion in the UCMS paradigm. Since XO is
predominating in the formation of NO within our diseased model, the inclusion of
febuxostat would provide information confirming XO involvement. Further, the addition of
febuxostat could theoretically inhibit the production of XO-mediated NO, altering the
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beneficial effects we have reported in aortic endothelial function. It is worth mentioning
that alone, febuxostat has been found to rescue endothelial health through the inhibition
of O2-∙ generation, and this could create cross play in the effects of UCMS on endothelial
function. Nonetheless, implementation of this combined nitrite/febuxostat treatment would
confirm mechanistic insight into the use of nitrite supplementation to preserve endothelial
health in chronically stressed mice.
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Chapter 6

Conclusion
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6.1 Conclusion
In conclusion, 8 weeks of chronic stress exposure via the UCMS paradigm elicited
changes in aortic vascular health. Chronic stress-induced aortic endothelial dysfunction
was mitigated by 8 weeks of 50mg/L sodium nitrite treatment. While functional differences
in aortic health were observed, chronic stress exposure and sodium nitrite treatment
caused no changes in the aortic structural profile or measurements of large elastic artery
stiffness. We divulged mechanistic insight into the role of oxidative stress and NO
bioavailability in the pathology of endothelial dysfunction attributed to chronic stress.
Further, we confirm improvements in endothelial dependent dilation due to reductions in
oxidative stress generation and subsequent increases in NO bioavailability upon
activation of the nitrate-nitrite-NO pathway. Sodium nitrite treatment is proven safe and
effective within our current study, and its role as a therapeutic within vascular disease is
becoming apparent even with clinical applications.
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